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Human skin fibroblast cultures have been employed to 
study the effects of a variety of vitamin A analogues 
(retinoids) on the expression of two enzymes involved in 
collagen degradation in the skin, collagenase and a ge-
latinolytic protease. In normal and recessive dystrophic 
epidermolysis bullosa fibroblast cultures, retinoic acid 
compounds were effective inhibitors of the accumulation 
of both enzymes in the culture medium with half-maxi-
mal inhibitions occurring at 0.25-1 p.M for collagenase 
and at 3-6 p.M for the gelatinolytic protease. Various 
retinoids exhibited differing degrees of inhibitory ac-
tions, so that at a 1 p.M concentration, relative inhibitions 
were: 13-cis-retinoic acid > all-trans-retinoic acid > ar-
omatic retinoid (Ro 10-9359) >> retinol. The retinoic 
acid-mediated decrease in collagenase activity was ac-
companied by a parallel decrease in immunoreactive 
collagenase protein, suggesting that the retinoic acids 
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were acting to inhibit synthesis of the enzyme. However, 
an additional effect of these agents was encountered. 
Although the retinoids themselves had no direct colla-
genase inhibitory action, medium derived from cultures 
maintained in these retinoids showed direct inhibitory 
capacity which was dependent both on the concentration 
of retinoic acid and on the length of time in culture. The 
results suggest that the retinoic acids modulate collagen-
ase in vitro by two mechanisms: by decreasing the syn-
thesis of enzyme protein and by modulating the expres-
sion of an inhibitory molecule. 
Collagenase is the rate-limiting enzyme in collagen degrada-
tion and is crucial for the initial characteristic cleavage of the 
collagen molecule [1]. Following this cleavage, at physiologic 
temperature the individual collagen chains become denatw·ed 
[2] and are further degraded by the gelatin-specific neutral 
protease, gelatinase [3-7]. For complete collagen degradation 
to occur in the skin, it is likely that the concerted, but sequen-
tial, actions of at least two enzymes-collagenase and gelati-
nase-are required [7-9]. 
Although vitamin A (retinol) and its derivatives (retinoids) 
constitute a class of compounds with many diverse actions, 
particularly on epithelial cells [10], their effects are not limited 
to this cell type. Thus, it is of interest that Brinckerhoff and 
coworkers [11,12] have shown that both naturally occurring all-
trans-retinoic acid and the synthetic retinoid, 13-cis-retinoic 
acid, inhibit collagenase expression in cultures of mesenchymal 
cells derived from human rheumatoid synovium. In other sys-
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terns, however, the effects of retinoids on various proteolytic 
enzymes differ, and this variability may depend on certain 
genetic or epigenetic characteristics of the given cell strains. 
For example, in SV -40 transformed 3T3 cells, 10 J.LM retinoic 
acid has been shown to cause a 5- to 6-fold increase in plasmin-
ogen activator, while in nontransformed cells, this stimulation 
was not observed [13]. Furthermore, in one therapeutic trial 
employing 13-cis-retinoic acid in a heritable keratinizing disor-
der of the skin, the retinoid decreased both ,8-glucuronidase 
a nd cathepsin D but caused no change in neutral protease of 
the skin [14]. 
In view of the modulatory effect of retinoic acid on rheuma-
toid synovial cells, we postulated that the retinoids might exert 
an effect on proteases involved in the t urnover of connective 
t issue in the skin. In addition, since certain pharmacologic 
agents-such as phenytoin-which inhibit collagenase synthe-
sis in vitro [15] have been shown to ameliorate the blistering 
and connective tissue fragility caused by excessive collagenase 
synthesis [16,17) in the hereditary blistering disorder, recessive 
dystrophic epidermolysis bullosa (RDEB) [16,18), it seemed 
reasonable to postulate that other drugs which function as 
inhibitors of collagenase expression might be found to be ther-
apeutically useful in this disease. In this study, we have em-
ployed human skin fibroblasts to examine the effects of reti-
noids on the collagen degradative enzymes. Our major aims 
were threefold: (a) to determine the effects of retinoids on 
collagenase and gelatinolytic protease expression in vitro, (b) to 
extend the findin gs on collagenase to RDEB cells and, if pos-
sible, to utilize an in vitro system to develop a rationale for 
possible therapeutic use of the compounds in RDEB, and (c) to 
determine the mechanism(s) of action of selected compounds 
in modulating collagenase in vitro and to characterize the 
phenotypic variability in these mechanisms. 
MATERIALS AND METHODS 
Fibroblast Cultures 
Skin fibroblast cultmes were established from normal volunteers and 
from patients with epidermolysis bullosa after obtaining informed con-
sent in accordance with the requirements of the Washington University 
Human Studies Committee (Table 1) . Cells were subcultivated in 
disposable plastic culture dishes or flasks (Falcon Plastics, Division of 
Becton Dickinson, Cockeysville, Maryland) in Dulbecco's modified 
Eagle's medium-high glucose plus glutamine with 30 mM Hepes buffer 
(pH 7.6) , 20% fetal calf serum, and 200 units of penicillin and 200 flg of 
streptomycin/ ml at 37° C in a 95% air:5% C02 atmosphere. In these 
experiments, fibroblasts were grown to early confluence (i.e., station-
ary), a cell density at which collagenase accumulation is greatest [19, 
20]. 
To determine the effects of the various retinoids on collagenase and/ 
or gelatinolytic protease expression, serum-containing medium was 
removed, the cell layers were washed 3 times with Hanks' balanced salt 
solution, and the cultures were maintained for 24-48 h in serum-free 
Dulbecco's modified Eagle's medium containing 10- 7 to 10- 5 M concen-
trations of the various retinoids or an appropriate amount of ethanol or 
TABLE I. Description of human shin fibroblast strains 
Cell strain 
Controls 
WUN 76130 
WUN 79477 
WUN 80547 
WUN 81647 
wuc 1224 
WUN 79423 
WUN 7558 
Sex 
F 
F 
M 
F 
F 
F 
M 
Recessive dystrophic epidermolysis bullosa 
WUE 7504 F 
WUE 80523 M 
WUE 76114 M 
Dominant epidermolysis buUosa simplex 
WUE 80530 M 
Age 
(years) 
20 
38 
10 
42 
40 
10 
29 
8 
1 
4 
1 mo 
dimethylsufoxide (DMSO) as a solvent control, as described by Brinck-
erhoff et al [11]. Retinol, and all- trans-retinoic acid were purchased 
from Sigma Chemical (St. Louis, Missouri) . The synthetic retinoids, 13-
cis-retinoic acid and Ro 10-9359, were generously provided by Dr. W. 
E. Scott of Hoffmann-La Roche (Nutley, New Jersey). Stock solu tions 
of all compounds were prepared at 10-3 M concentrations in ethanol or 
DMSO and were stored at -70°C until diluted with culture medium 
for use. 
Enzyme Assays 
For collagenase assay, human skin fibroblast culture medium was 
activated proteolytically with trypsin as described previously [21]. For 
each enzyme preparation, a range of trypsin concentrations (0.2-5 flg of 
t rypsin per 100 fll enzyme sample) was employed to ensure that maximal 
activity was measured. After preincubation with trypsin for 10 min at 
25°C, at least a 5-fold molar excess of soybean trypsin inhibitor was 
added to inhibit further trypsin activity. Each mi..xtme was then assayed 
at 37°C in 0.05 M Tris-HCl (pH 7.5) in the presence of 10 mM CaCb 
using native, reconstituted [ 14C]glycine-labeled collagen fibrils contain-
ing 4000- 7000 cpm per substrate gel [22]. The specific activity of the 
[' ''C]collagen was 25,000 cpm/ mg. Ethanol and DMSO, in the concen-
trations employed in these experiments, did not interfere with the 
assay. 
The assay used to measure gelatinolytic activity was a slight modi-
fication of that described by Harris and Krane [3]. T he radioactive 
gelatin was prepared by thermally denaturing [' ''C]glycine-labeled 
guinea pig skin collagen at 60 °C for 20 min. Following trypsin activation 
of the fibroblast cultme medium containing the putative progelatinase 
at 37°C for 20 min, the mixture was incubated with the [' 4C]glycine-
labeled gelatin at 37°C [7]. The reaction was terminated by the addition 
of 100% (w/ v) trichloroacetic acid to give a final concentration of 20%. 
After cooling on ice for 30 min, the reaction tubes were centrifuged at 
12,000 g, and the supernatant fractions were counted in a liquid scintil-
lation spectrometer [7]. Since DMSO was found to be a slight inhibitor 
of gelatinolytic activity, all experiments on the effects of the retinoids 
on gelatinase expression were performed using ethanol as the solvent. 
Inhibitor Assay 
To determine the capacity of the medium obtained from retinoid-
containing cultures to inhibit collagenase activity directly, varying 
concentrations of medium were mixed with fully active, purified human 
skin collagenase, and the ent ire mixture was assayed using radioactive 
collagen fibrils as described above. For these experiments the active 
collagenase was obtained from human skin explants grown in serum-
free medium and purified by the method of Stricklin et al [8]. The 
results were expressed as the percent inhibition of exogenous collagen-
ase activity by the retinoid-containing medium over that found in 
controls containing exogenous collagenase and an equal concentration 
of medium derived from cultures grown in the appropriate organic 
solvent (i.e., ethanol or DMSO). Direct addition of retinol or retinoids 
to the collagenase or gelatinase was not in itself inhibitory in these 
assays. 
Radioimmunoassay of Collagenase 
In order to assess the capacity of the retinoids to inhibit collagenase 
synthesis, as reflected by a decrease in immunoreactive material in the 
medium, immunoreactive collagenase was measured by a slight modi-
fication of the double antibody radioimmunoassay previously reported 
[23]. The procollagenase used as the unlabeled standard and for iodi-
nation was pw·ified to homogeneity [8]. The antiserum prepared with 
this immunogen [9] gave a single immunoprecipitin band when reacted 
in gel diffusion analysis [24] either with the crude culture medium or 
with the electrophoretically homogeneous human skin collagenase. In 
addition, a gamma globulin preparation of the antiserum produced 
>90% inhibition of collagenase activity after reacting 2 h at 37°C 
compared with < 5% inhibition by a nonimmune gamma globulin 
preparation [9]. Standard radioimmunoassay curves were derived by 
incubating duplicate disposable plastic microfuge tubes (Beckman In-
struments, Inc.) that contained a 1:2500 dilution of t he gamma globulin 
fraction of antiserum to human skin collagenase, 125!-labeled human 
skin collagenase (-20,000 cpm/tube) , and 0-100 ng of electrophoreti-
cally homogeneous human skin collagenase in a total volume of 250 fll. 
After incubation for 24 h at 4°C, goat an tirabbit IgG was added in 
excess, and the resulting precipitates were isolated, washed, and 
counted in a single-channel gamma scintillation spectrometer. Un-
knowns were assayed for enzyme protein in an identical fashion using 
150-fll portions of serial doubling dilutions of the enzyme preparations. 
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Controls in which nonimmune rabbit gamma globulin was substituted 
for specific antiserum were routinely included. 
Other Assays 
Total protein synthesis was determined in fibroblast cultures in the 
presence of either retinoids or solvent controls. Under serum-free 
conditions identical to those described above for assessing collagenase 
expression, a 3H-labeled amino acid mixtw-e (10 1-'Ci/ml) was added for 
24 h and total protein synthesis was determined as the amount of aH-
Iabeled amino acids incorporated into 10% trichloroacetic acid-precipi-
table material in the medium and cells. The protein content of the cell 
layer was determined by the method of Lowry et a] (25] using a bovine 
serum albumin standard. Statistical analysis of the data was performed 
using Student's t-test. 
RESULTS 
Initially we investigated the capacity of varying concentra-
tions of retinoic acid, when added to human skin fibroblast 
cultures, to inhibit the accumulation of collagenase in the 
culture medium. The data in Fig 1 depict the results from 4 
different experiments comparing the effects of retinoic acid in 
both normal and epidermolysis bullosa fibroblast cultures. The 
addition of 13-cis-retinoic acid to the culture medium resulted 
in a dose-dependent inhibition of collagenase expression with 
half-maximal inhibition occurring at 0.25-1 J..I.M . In these exper-
40 A Control Cells 
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13-cis RETINOIC ACID CONCENTRATION {IJM) 
FIG 1. Retinoic acid-mediated dose-dependent inhibition of colla-
genase expression in normal and epidermolysis bullosa fibroblast cul-
tures. Fibroblasts grown in 10-cm2 culture plates were placed in serum-
free medium containing 0.1-10 llM concentrations of 13-cis-retinoic acid 
for 24 h. Following trypsin activation, collagenase activity was quanti-
tated in the medium and the data are expressed as the mean ± SE 
total enzyme activity per mg cell protein from 4 experiments. (A) e, 
Control cells: WUN 76130, WUN 79477, WUN 80547, WUE 80530. (B) 
0 , RDEB cells: WUE 76114 (2 isolates), WUE 80523, WUE 7504. 
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iments, both normal fibroblasts and cells from a genetically 
distinct type of epidermolysis bullosa, dominant epidermolysis 
bullosa simplex, served as controls (Fig 1A) for comparison with 
the amount of collagenase in the medium of the RDEB cells. 
The degree of inhibition in the control cultures varied between 
50 and 100% at the highest drug concentration. In the case of 
the 4 RDEB cell strains (Fig 1B), despite the fact that the 
initial collagenase levels in the medium were about 3-fold 
greater than in the control cells, 13-cis-retinoic acid also pro-
duced 70-100% inhibition. No differences were found between 
the normal and mutant cells in their capacity to respond to the 
retinoid. 
The effect of retinoic acid on the expression of gelatinolytic 
activity was also examined, as shown for 2 of 7 such experiments 
(Fig 2). In contrast to the case with collagenase, retinoic acid 
was significantly less effective at 0.5, 1, and 5 J..tM drug concen-
trations as an inhibitor of gelatinolytic protease accumulation 
in the medium with half-maximal inhibition occm-ring between 
3 and 6 J..tM. At the highest concentration of retinoic acid tested 
(10 J..tM), the inhibitory effects on collagenase and the gelatinase 
were not significantly different. In these experiments, as well as 
those depicted in Fig 1, attempts to increase the retinoid 
concentration to 100 J..I.M resulted in apparent toxicity to the 
fibroblasts as manifested by marked granularity of the cyto-
plasm. 
To compare the kinetic characteristics and the relative ca-
pacities of the two forms of retinoic acid-naturally occuning 
all-trans and synthetic 13-cis-in inhibiting collagenase and 
gelatinolytic protease expression, we utilized one concentration 
of drug (10 J..I.M) for varying times (24 and 48 h) in both normal 
and RDEB fibroblast cultures (Fig 3). In the RDEB cultures, 
collagenase accumulated in the culture medium at about 3.5 
times the rate of accumulation in normal cell cultmes (Fig 
3A,B), a finding reflective of our previous studies which showed 
enhanced biosynthesis of this enzyme [17). In these experi-
ments, both 13-cis- and all-trans-retinoic acid inhibited colla-
genase expression by 40- 60% at 24 h and by 60-80% at 48 h. 
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FIG 2. Retinoic acid-mediated inhibition of gelatinolytic protease 
expression in normal fibroblast cultures. Fibroblasts grown in 75-cm2 
culture flasks were placed in serum-free medium containing 0.1-10 !lM 
13-cis-retinoic acid. Following trypsin activation, gelatinase activity 
was measuJ"ed and expressed as the mean ± SE total enzyme activity 
per mg cell protein. Cultures: WUC 1224, WUN 79423. 
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The parent compound, retinol, failed to inhibit collagenase 
accumulation in the control cells (Fig 3A) but produced -35% 
inhibition in the RDEB cells (Fig 3B). The reason for the 
different responsiveness to retinol in this particulru: experiment 
is at present unknown. 
Since it has been suggested that the increased synthesis of 
collagenase in RDEB may represent a genetic characteristic of 
this disease [16], we examined the synthesis and secretion of 
the presumed second enzyme in the collagen deg:radative path-
way-a gelatinolytic protease (Fig 3C,D). No significant differ-
ences were found between control and mutant cell strains in 
the rates of accumulation of this gelatinase in the absence of 
retinoids. Both 13-cis- and all-trans-retinoic acid produced a 
50-70% inhibition of gelatinase accumulation at 48 h. Retinol 
gave no significant inhibition (Fig 3C,D). Since the expression 
of the gelatinolytic protease was equal in the two cell types, the 
data suggest that only the increase in the rate of synthesis of 
collagenase served as a biochemical marker for discrimination 
ofRDEB. 
We next performed additional experiments to determine the 
relative specificities of the various retinoids in inhibiting colla-
genase expression. To accomplish this, we measured the effect 
of a 1 J.l.M concentration of each retinoid on collagenase activity 
in the medium per mg cell protein and on total protein synthesis 
as reflected by a decrease in total newly synthesized 3H-labeled 
trichloroacetic acid-precipitable protein (in the medium+ cells) 
per mg cell protein (Fig 4). The retinoic acid compounds were 
the most effective inhibitors of collagenase. No statistically 
significant difference between 13-cis- and all-trans-retinoic acid 
in terms of collagenase inhibition was noted; however, each 
compound produced a significantly greater inhibition of colla-
genase than of total protein synthesis (p < 0.05). The parent 
compound, retinol, was the least effective agent, while the 
aromatic retinoid, Ro 10-9359, showed only minor inhibitory 
capacity. The specificity of the retinoic acid effects on collagen-
ase expression is attested to by the fact that retinol and Ro 10-
9359 produced no greater inhibition of collagenase expression 
than of total protein synthesis. 
To gain insight into the possible mechanism(s) for the action 
of retinoic acid on collagenase production, we measured both 
collagenase activity and immunoreactive enzyme protein in the 
culture medium (Table II). In each case the inhibition of 
collagenase activity was paralleled by a decrease in immuno-
reactive protein in the medium. For example, as shown in 
Experiments I and 2, activity was inhibited 50 and 55% by 10 
f.LM 13-cis-retinoic acid, while immunoreactive protein was in-
hibited 46 and 61%. These results suggest that the retinoids act 
primarily by inhibiting the synthesis of enzyme protein. In 
Experiment 2 (Table II) the specificity of this effect was also 
examined by quantitating the incorporation of '1H -labeled 
amino acids into 10% trichloroacetic acid-precipitable material 
in the medium and cells of cultures containing the highest 
concentration of retinoic acid employed in the studies, 10 J.LM. 
Compared to the control cultures maintained in the DMSO 
vehicle alone (396.6 cpm X 10- :J / mg protein), protein synthesis 
was 274.9 cpm X 10- ";mg protein in the presence of 10 f.LM 13-
cis-retinoic acid (31% inhibition) , 345.2 cpm X 10- 3/mg protein 
in the presence of 10 J.l.M all-trans-retinoic acid (13% inhibition), 
and 383.7 cpm X 10- 3/ mg protein in the presence of 10 f.LM 
retinol (3% inhibition). Thus, even at the highest levels of 
retinoic acid employed for these studies, which produced ap-
proximately a 60% decrease in collagenase activity and enzyme 
protein, there was only half as great a decrease in total protein 
synthesis in the presence of the 13-cis compound and less than 
one-fifth the decrease in total protein synthesis in the presence 
of the all-trans compound. 
In some cases (e.g., Table II, Experiment 3) the decrease in 
trypsin activatable collagenase activity in the medium was 
greater than could be accounted for solely by a decrease . in 
immunoreactive enzyme protein. Thus, we examined the cui-
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FIG 3. Comparative effects of retinoids on collagenase and gelatin-
olytic protease accumulation in the culture medium of normal and 
RDEB fibroblasts. Cultures grown in 75-cm2 cultuTe flasks were placed 
in serum-free medium containing 10 J.LM concentrations of retinoic acid, 
retinol, or an appropriate concentration of ethanol as the solvent 
control for 24 or 48 h. Trypsin-activatable collagenase and gelatinase 
were assayed at 37°C and the data are expressed as the total enzyme 
activity per mg cell protein. A , Collagenase activity in control cells 
(WUN 81647). B, Collagenase activity in RDEB cells (WUE 7504). C, 
Gelatinase activity in control cells. D, Gelatinase activity in RDEB 
cells. e, ethanol control; 0 , retinol; •, 13-cis-retinoic acid; 0, all-trans-
retinoic acid. 
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FIG 4. Specificity of the inhibitory effects of various retinoids on 
collagenase expression. Fibroblasts grown in 75-cm2 culture flasks were 
placed in serum-free medium for 24 h in t he presence of a 1 J.LM 
concentration of each of the various retinoids. Trypsi..n-activatable 
collagenase per mg cell protein was measured at 37°C and the data are 
expressed as the % inhibition obtained (mean ± SE) relative to control 
cultures containing ethanol or DMSO as the solvent. Replicate serum-
free flasks were also maintained in a 1 J.LM concentration of each retinoid 
and labeled with -5 J.LCi!ml [3H]leucine for 24 h. Protein synthesis was 
then quantitated as total 10% trichloracetic acid-precipitable labeled 
material in the medium and cells per mg cell protein. The data are 
expressed as the % inhibition (mean ± SE). Open bars, inhibition of 
collagenase; cross·hatched bars, inhibition of total protein synthesis. 
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TABLE II. Effect of retinoic acid on collagenase activity and immunoreactive protein" 
Retinoid Collagenase Immunoreactive 
Culture concentration activity• protein .. 
JlM cpm/mg protein %1 ng/mg pro tein %1 
Experiment 1 
control 0 30,760 0 1,285 0 
13-cis·RA 1 23,160 25 1,100 14 
10 15,430 50 695 46 
Experiment 2 
control 0 31,995 0 1,100 0 
13-cis·RA 1 26,090 18 1,010 8 
10 14,515 55 430 61 
all-trans·RA 1 29,580 8 1,440 0 
10 10,815 66 260 76 
retinol 1 22,655 29 1,180 0 
10 32,405 0 ND 
Experiment 3 
control 0 27,685 0 1,045 0 
13-cis·RA 1 35,730 0 1,010 3 
10 4,090 85 520 50 
"In all 3 experiments replicate 75-cm2 culture flasks of WUN 80507 cells or WUN 81647 cells were placed serum-free for 24 hr in the presence 
of varying concentrations of the retinoids prior to harvesting the medium to assay for collagenase activity and radioimmunoassayable enzyme 
protein. RA, retinoic acid. 
"Collagenase activity is expressed as the total activity per mg cell protein and as the % inhibition (%I) relative to the control cultmes. 
,. Immunoreactive protein is expressed as the total ng of enzyme protein per mg cell protein and as the % inhibition (%I) relative to the control 
cultures. 
ture medium for the presence of an inhibitor of collagenase 
activity. For these studies, crude culture medium derived from 
cells maintained in the presence of 10 J.LM retinoic acid was 
added in varying concentrations to a constant amount of fully 
active, purified human skin collagenase to detect any direct 
enzyme inhibitory effect. Fig 5 depicts a representative inhibi-
tion curve obtained from one such experiment. The concentra-
tion-dependent direct inhibition of activity observed suggests 
that a second mechanism for modulation of collagenase may be 
present, i.e., that the retinoid may enhance secretion of an 
inhibitor of collagenase activity. 
To explore this ·possibility further, experiments were per-
formed to determine whether the enhanced amount of inhibitor 
was dependent upon the concentration of retinoid in the culture 
medium. As shown by the two cell strains in Fig 6, after 
culturing the fibroblasts in varying concentrations of 13-cis-
retinoic acid, equivalent volumes of culture medium contained 
increasingly greater direct collagenase inhibitory capacity as 
the concentration of retinoid in the growth medium increased. 
Here, it should be reemphasized that the direct addition of any 
of the retinoids alone to the enzyme assay did not inhibit 
activity, and, thus, . the drugs exerted their effects through 
modulation of cellular function. 
In a second series of experiments the phenotypic variability 
in the expression of this inhibitor was examined (Table III). 
Three points emerged from these data. First, considerable 
variability was observed among cell strains in the expression of 
this inhibitor. Second, both normal and RDEB cells had the 
capacity to secrete this inhibitor into the culture medium. 
Third, the variability in inhibition among compounds seemed 
in some cases to be related to the length of time in culture in 
the presence of retinoid. In particular, at 48 h, 13-cis-retinoic 
acid was associated with greater expression of inhibition. This 
effect <;an be seen in Experiments 3, 4, and 5 in which the mean 
( ± SE) inhibition per 100 J.L1 of medium was .46. 7 ± 11.1% for 13-
cis-retinoic acid compared to 11.5 ± 1.5% for all-trans-retinoic 
acid (p < 0.05). Furthermore, as can be noted in Experiment 5, 
retinol was less than half as effective as 13-cis-retinoic acid in 
modulating the expression of the inhibitor. 
Initial characterization of the inhibitor found in the retinoic 
acid cultures revealed it to be a nondialyzable macromolecule 
which was heat stable when exposed to heating at 60°C for 20 
min. These characteristics are similar to those reported previ-
ously from this laboratory for the inhibitor isolated from normal 
human skin fibroblast cultures by Welgus et al [26]. In addition, 
100 200 300 
INHIBITOR -CONTAINING MEDIUM (JJI) 
FIG 5. Direct inhibition of collagenase activity by cultme medium 
derived fTom fibroblasts maintained in a 10 p.M concentration of 13-cis-
retinoic acid. Increasing concentrations of inhibitor-containing medium 
were added to fully active, pmified human skin collagenase and the 
entire mixture (325 p.l) was assayed at 37°C for 1 h using [14C]glycine-
labeled collagen as a substrate. Collagenase activity in the absence of 
the inhibitor-containing medium released 621 cpm above the buffer 
blank. In this experiment, culture medium from cells cultmed in the 
absence of retinoic acid contained no inhibitor activity. 
this putative inhibitory molecule did not bind to carboxymeth-
ylcellulose (CM-cellulose) in 1 mM Tris-HCl, pH 7.5, a finding 
also characteristic of purified human skin fibroblast inhibitor 
(unpublished observations) which· we utilized to purify the 
molecule. Like the inhibition achieved with crude retinoid-
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FIG 6. Retinoic acid stimulation of collagenase inhibitor in normal 
human skin fibroblast cultures. Fibroblasts grown in 75-cm2 culture 
flasks were placed serum-free for 24 h in the presence of 0-10 I'M 13-
cis-retinoic acid. A fixed concentration of medium (100 1'1) was added 
to fully active, pw-ified human skin collagenase and the ent ire mixture 
was assayed at 37°C for 2 h using a radioactive substrate. The data 
represent the % inhibition achieved relative to the inhibitory capacity 
found in control cultures maintained in the solvent alone. Collagenase 
activity obtained using exogenous collagenase and control medium was 
732 cpm above blank for WUN 79477 and 692 cpm above blank for 
WUN 80547. e, WUN 79477; 0, WUN 80547. 
TABLE III. Inhibition of collagenase activity by culture medium 
derived from fibroblasts cultured in. the presence of 10 !LM retinoic 
acid" 
Retinoid in 
cul ture 
Experiment I 
13-cis-RA 
Experiment 2 
13-cis-RA 
all-tra.ns-RA 
Experiment 3 
13-cis-RA 
13-cis-RA 
Experiment 4 
13-cis-RA 
13-cis-RA 
all-tran.s-RA 
all-trans-RA 
Experiment 5 
13-cis-RA 
13-cis-RA 
all-trans-RA 
retinol 
Cell strain 
Control strain 
WUN 79477 
Control stra in 
WUN 80547 
Control strain 
WUN 81647 
Control strain 
WUN 7558 
RDEB strain 
WUE 7504 
Time Inhibition 
hr % 
24 38 
24 43 
24 25 
24 0 
48 50 
24 0 
48 26 
24 0 
48 10 
24 44 
48 64 
48 13 
48 19 
" In each experiment, a 100-~ portion of medium derived from 
cultures maintained in the organic solvent alone (control medium) or 
from cultures maintained in a 10 I'M concentration of retinoid (retinoid 
medium) was added to exogenous, fully active, pw-ified human skin 
collagenase. T he entire reaction mixture was then assayed at 37°C 
using a radioactive collagen substrate. The results are expressed as the 
inhibition of activity by the retinoid-containing medium over that seen 
in the control medium. In these experiments the enzyme activity of. the 
exogenous collagenase + control medium was 550-1300 cpm. RA, 
retinoic acid. 
-~ 
z 
0 
I-
-
o:l 
-
I 
z 
....... 
80 
60 
• 
40 
20 
QL-------L-------~----~~----~~~ 
50 75 100 
INHIBITOR -CONTAINING CARBOXY-
METHYCELLULOSE FALL- THROUGH (~I) 
FIG 7. Dose-dependent inhibit ion of collagenase activity by partially 
pw·ified inhibitor. Varying concentrations of inhibitor-containing me-
dium partially pUl'ified by passage over CM-cellulose were added to 
fu lly active, purified human skin collagenase and the entire mixture 
was assayed at 37°C for 1 h using radioactive substrate. The data are 
presented as % inhibit ion achieved relative to the enzyme activity seen 
in a reaction mixture containing no inhibitor (589 cpm above blank). 
derived culture medium (Fig 5), the material partially pmified 
by its failme to bind to CM-cellulose gave a dose-dependent 
inhibition of collagenase activity (Fig 7). This preparation in-
hibited t he gelatinolytic protease as well, with 25 0 of the CM-
cellulose fall-through producing an ~35% inhibition of activity. 
This observation also suggests that the inhibitor being modu-
lated in the retinoid cultures was the fibroblast-derived inhibi-
tor found in normal cultmes, since human skin gelatinase is 
known to be inhibited by this protein [7]. 
DISCUSSION 
A major differentiated function of skin fibroblasts is to syn-
thesize and secrete collagenase, as shown by the fact that up to 
1% of the biosynthetic capacity of these cells is devoted to this 
process [27). In the present studies, we have shown that certain 
derivatives of vitamin A exert profound effects on human skin 
fibroblasts, t hus altering the synthesis of a major gene product 
of the cells. Unlike the effects of these agents on epith elial cells, 
however, many of which are mediated through growth and/ or 
differentiation [28], the effects on collagenase were observed 
under conditions independent of cellular growth, i.e., in serum-
free confluent cultmes. 
The degree of inhibit~on of collagenase expression elicited by 
retinoic acid in human skin fibroblast cultmes was similar to 
that observed by Brinckerhoff et al [11] in cultmes of rheu-
matoid synovial cells. It should be emphasized, however, that 
certain observations, which may in part reflect inherent differ-
ences between the synovial cell and skin fibroblast systems, 
have emerged from om studies. First, in contrast to the synovial 
cells (11], human skin fibroblasts elaborate a gelatinolytic pro-
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tease. Although other cells and tissues have been shown to 
contain gelatinolytic enzymes [3-6], within the context of con-
nective tissue turnover in normal skin, it is reasonable to 
hypothesize that the gelatinase found in cultured skin [7] may 
represent the enzyme for completing collagen degradation after 
the rate-limiting step involving collagenase. Thus, the effect 
that retinoic acid exerted on gelatinase expression- although 
occurring only at a higher concentration than that required to 
inhibit collagenase (Fig 2)-underscores the potential for this 
class of compounds as pharmacologic modulators at two levels 
of connective tissue degradation. 
By measuring immunoreactive collagenase protein in the 
culture medium (Table II), we have shown that the retinoic 
acid-mediated decrease in trypsin-activatable collagenase was 
accompanied by a parallel decrease in enzyme protein. We have 
previously demonstrated that under normal biosynthetic con-
ditions there is little intracellular storage of collagenase, and 
that the rate of secretion of enzyme protein into the medium is 
reflective of de novo synthesis; indeed, after 12-24 h in culture 
more than 85% of the enzyme protein is found in the culture 
medium [27]. Thus, although detailed biosynthetic studies will 
ultimately be required to assign a specific cellular mechanism 
of action for these drugs on collagenase, the data suggest that 
the retinoic acids act primarily by inhibiting synthesis of the 
enzyme. The specificity of this effect is supported by the obser-
vation that at a concentration of 1 p.M retinoic acid-a level that 
produced approximately half-maximal inhibition of collagenase 
expression-there was no more than an 11% inhibition of total 
protein synthesis (Fig 4). Furthermore, with both collagenase 
and the gelatinolytic protease, even a 10 J.LM concentration of 
13-cis-retinoic acid produced only half as great an inhibition of 
total protein synthesis (31% inhibition) as of the expression of 
these enzymes (50-80% inhibition). 
It should be noted, however, that inhibition of enzyme syn-
thesis need not be the only mechanism for modulating colla-
genase action. In some cell strains, in contrast to the rheumatoid 
synovial cell system [11], we observed a greater reduction in 
collagenase activity than could be accounted for solely by a 
decrease in enzyme protein. By simple "add-back" experiments 
in which media derived from cultures maintained in retinoids 
were added to fully active collagenase, the presence of an 
inhibitor was documented (Figs 5-7, Table III). The appearance 
of this inhibitor was dependent upon the concentration of 
retinoic acid in the medium, since about 3 times as much was 
seen in cultures maintained in 10 p.M 13-cis-retinoic acid as in 
those maintained in 0.1 J.LM 13-cis-retinoic acid (Fig 6). Because 
of the thermal stability and behavior on CM-cellulose of this 
inhibitory macromolecule, it is likely that it is identical to the 
inhibitor isolated previously from unperturbed cultures of hu-
man skin fibroblasts [26]. Although a number of collagenase 
inhibitors which share certain, but not all, characteristics has 
been isolated from various tissue sources [29-37], the differ-
ences in these inhibitors may reflect the existence of tissue-
specific minor variations. Thus, it would be of interest to assess 
the modulatory potential of the various retinoids on the expres-
sion of other tissue inhibitors. 
The fact that the retinoic acids-especially 13-cis-retinoic 
acid-exert their effects on collagenase by two different mech-
anisms may hav:e important therapeutic implications in RDEB. 
In this disorder, both morphologic [38] and biochemical [16, 
17,39,40] evidence suggest that the blistering and tissue fragility 
may in part result from increased synthesis of collagenase. 
Indeed, the anticonvulsant drug, phenytoin, which inhibits col-
lagenase expression in vitro [15], has been shown to ameliorate 
blistering when given clinically [15,18]. Thus, it is reasonable to 
postulate that drugs that decrease collagenase synthesis or 
activity might be therapeutically useful in the disease. In the 
case of the retinoic acids compounds, the evidence accumulated 
here would speak for a dual rationale for pharmacologic inter-
vention with retinoic acid-decreased synthesis of enzyme pro-
Vol. 81, No . 2 
tein and enhanced expression of an inhibitor. Furthermore, the 
levels of retinoic acid used in this study (0.1 p.M "" 30 ng/ml) 
should be pharmacologically achievable, since the normal 
plasma concentration of retinoic acid is 1- 3 ng/ml [ 41]. 
We gratefully acknowledge the excellent technical assistance of 
Messrs. David Meehan, Stanley White, Thomas Horan, and William 
Burniski. 
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Corticosteroid Atrophy in Human Skin. A Study by Light, Scanning, and 
Transmission Electron Microscopy 
PERCY LEHMANN, M.D.,* PEISHU ZHENG, M.D., ROBERT M. LAVKER, PH.D., AND 
ALBERT M. KLIGMAN, M .D., PH.D. 
Duhring Laboratories, Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, U.S.A. 
Steroid atrophy was induced in 3 volunteers by the 
continuous, occlusive application of clobetasol propio-
nate to the forearms for 6 weeks. The changes were 
followed sequentially by light, scanning, and transmis-
sion electron microscopy. A 59% decrease in viable epi-
dermal thickness was noted after the sixth week of treat-
ment, as well as a flattening of the dermal-epidermal 
junction. The 3-dimensional architecture of the dermis 
was strikingly reorganized. This was largely brought 
about by resorption of the ground substance as revealed 
by a progressive dimunition of Hale's stain for acid 
mucopolysaccharides. Loss of ground substance resulted 
in decreased spaces between collagen and elastic fibers 
as shown by scanning and transmission electron micros-
copy. The fibrous network consequently collapsed, yield-
ing a more compact papillary and reticular dermis. This 
compression ·caused the reorientation of both collagen 
and elastic fibers. However, no differences in collagen 
and elastin fine structure were noted. Fibroblasts were 
shrunken but not reduced in density. A marked decrease 
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in number of mast cells was noted in 3-week specimens 
and virtually no mast cells were observed after 6 weeks. 
We found that the primary effect of short-term steroid 
use was a rearrangement of the geometry of the dermal 
fibrous network. This was not due to alterations in the 
fibers themselves but a secondary consequence of the 
loss of ground substance. 
Clinicians are all too familiar with the atrophogenic effects of 
potent topical steroids. The signs include telangiectasia, thin-
ning (depression), increased transparency, shininess, with loss 
of skin markings and sometimes striae [1-3]. There is little 
understanding of the mechanisms of these changes. Histology 
has routinely been used to confirm the production of atrophy 
by corticosteroids; however, these studies have resulted in 
divergent and even contradictory observations. Agreement ex-
ists only in relation to the epidermis, which is reduced to 3-4 
cell layers of shrunken, pyknotic cells with loss of rete pegs [ 4-
9]. Thinning of the dermis has been verified histometrically as 
well as radiologically [10-13], yet different workers have been 
unable to agree on the main alterations of the dermal matrix. 
Wilson Jones [5] applied 2 potent steroids occlusively for 1 
month to the forearms ·of 9 volunteers. By light microscopy, 
epidermal atrophy was marked but dermal changes were not 
noted. Conversely, in another study on corticosteroid atrophy, 
Frosch et al [14] concluded that there was virtual ablation of 
the papillary dermis. 
Ultrastructural studies have also revealed that steroids cause 
marked changes in the fibrous components of the dermis, but 
